newsfilter
← Latest News
GlobeNewswire·

Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum

IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare,